Moira Garraus

Prognostic factors and outcomes for osteosarcoma: An international collaboration

Emilios E. Pakos, Andreas Nearchou, R. J. Grimer et al. · European Journal of Cancer · 2009 · 195 citations · Full text

Medicine, Oncology, Surgery +14

Naxitamab combined with granulocyte‐macrophage colony‐stimulating factor as consolidation for high‐risk neuroblastoma patients in complete remission

Alicia Castañeda, Maite Gorostegui, Vicente Santa‐María et al. · Pediatric Blood & Cancer · 2021 · 30 citations

Medicine, Oncology, Pharmacotherapy +10

Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas

Helena Castillo‐Ecija, Guillem Pascual‐Pasto, Sara Pérez‐Jaume et al. · The Journal of Pathology Clinical Research · 2021 · 27 citations · Full text

Medicine, Cancer Biology, Oncology +16

Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes

Juan Pablo Muñoz, Cristina Larrosa, Saray Chamorro et al. · Cancers · 2023 · 25 citations · Full text

Medicine, Oncology, Pharmacology +14

The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies

Jaume Mora, Alicia Castañeda, Miguel Flores et al. · Frontiers in Pharmacology · 2020 · 23 citations · Full text

Medicine, Immunology, Oncology +17